Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Insider Confidence In Top Growth Companies For November 2024

In This Article:

As global markets experience a broad-based rally, with U.S. indexes nearing record highs and smaller-cap stocks outperforming their larger counterparts, investor sentiment is buoyed by strong labor market data and positive housing reports. Amidst this backdrop of economic optimism, growth companies with high insider ownership can be particularly appealing as they often signal management's confidence in the company's potential to navigate current uncertainties and capitalize on opportunities for expansion.

Top 10 Growth Companies With High Insider Ownership

Name

Insider Ownership

Earnings Growth

People & Technology (KOSDAQ:A137400)

16.4%

37.3%

Seojin SystemLtd (KOSDAQ:A178320)

31.1%

43.2%

Archean Chemical Industries (NSEI:ACI)

22.9%

41.3%

SKS Technologies Group (ASX:SKS)

32.4%

24.8%

Medley (TSE:4480)

34%

31.7%

Findi (ASX:FND)

34.8%

71.5%

Plenti Group (ASX:PLT)

12.8%

120.1%

Fulin Precision (SZSE:300432)

13.6%

66.7%

Brightstar Resources (ASX:BTR)

16.2%

84.6%

Global Tax Free (KOSDAQ:A204620)

19.9%

67.5%

Click here to see the full list of 1515 stocks from our Fast Growing Companies With High Insider Ownership screener.

We'll examine a selection from our screener results.

Pharmanutra

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Pharmanutra S.p.A. is a pharmaceutical and nutraceutical company that focuses on researching, designing, developing, and marketing nutritional supplements and medical devices across Italy, Europe, the Middle East, South America, the Far East, and internationally with a market cap of €532.28 million.

Operations: The company's revenue segments are comprised of €5.49 million from Akern, €68.35 million from Italy, and €38.40 million from international markets outside Italy.

Insider Ownership: 10.7%

Earnings Growth Forecast: 18.5% p.a.

Pharmanutra's recent earnings report shows strong growth, with sales reaching €83.47 million for the first nine months of 2024, up from €71.43 million a year ago. The company's revenue and net income have also increased significantly, reflecting robust financial health. Although insider trading data over the past three months is unavailable, analysts agree on a potential stock price rise of 52.2%. Pharmanutra's earnings are forecast to grow at 18.5% annually, outpacing the Italian market average of 7.3%.

BIT:PHN Ownership Breakdown as at Nov 2024
BIT:PHN Ownership Breakdown as at Nov 2024

Geo Energy Resources

Simply Wall St Growth Rating: ★★★★★★

Overview: Geo Energy Resources Limited is an investment holding company involved in the mining, production, and trading of coal with a market cap of SGD378.49 million.